Target intelligence / Profile preview

Novel transcript, antisense to RAB31 (ENSG00000285653)

Target
ENSG00000285653
Molecular classification
Non-coding RNA, Antisense transcript
01

Overview

This entity refers to a non-coding RNA transcript found in the human genome, transcribed antisense to the RAB31 gene (RAB31, member RAS oncogene family)[1]. Antisense transcripts in general can modulate the expression, stability, or processing of their complementary sense mRNAs, largely through chromatin modification, transcriptional interference, and formation of RNA duplexes influencing splicing, translation, or degradation[2][3]. For this specific transcript (ENSG00000285653), no experimentally validated biological function, disease association, or drug interaction has been reported. Its principal scientific interest lies in its classification as an antisense non-coding RNA, which may have regulatory effects on the neighboring RAB31 gene via mechanisms observed for other natural antisense transcripts, including transcriptional interference and chromatin modification. However, its functional role and clinical significance remain unknown[1][2][3].

Other names
Novel transcript, antisense to RAB31ENSG00000285653
02

Mechanism of action

Not applicable, as there are no drugs targeting this transcript.

03

Biological functions

May modulate chromatin architecture near the RAB31 locus via antisense transcription mechanismsPotentially influences the expression or stability of RAB31 sense transcript through transcriptional interference, RNA masking, or dsRNA-dependent processes common to natural antisense transcripts
04

Disease associations

None specifically documented; general effects of antisense RNAs may relate to gene regulation, but disease associations for this specific transcript have not been reported

Beyond the preview

Go deeper on Novel transcript, antisense to RAB31 (ENSG00000285653).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RAB31 (ENSG00000285653).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call